PFE compared with SKT: revenue, margins and what each company keeps, and the suppliers and customers both name

PFEPfizer Inc

Mkt capRevenueRevenue

SKTTanger Inc.

Mkt capRevenueRevenue

Compare

PFEPfizer Inc

SKTTanger Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

PFE

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±3.7%▼−2.18%×0.59

Q2 FY26±3.3%▲+1.52%×0.45

Q1 FY26±3.5%▲+0.57%×0.17

Feb 3 '26±3.2%▼−3.34%×1.03

SKT

0 of 4at or beyond implied

Reportimpliedrealized× implied

Nov 5 '26thin chain±8.0%▼−0.18%×0.03

Q2 FY26±4.6%▼−0.42%×0.09

= impliedPFE realized, solidSKT realized, hatchedOne scale, both sides: full bar = 8%× = |realized| ÷ impliedSource: market data

Q1 FY26±7.7%▼−1.97%×0.26

Feb 25 '26±7.6%▲+5.79%×0.76

PFEPfizer Inc

29.39▼−0.21%· post 29.35

Mkt cap$167.5BRevenue$16.6BQ3 FY26Revenue$62.6BFY25

SKTTanger Inc.

38.68▲+0.74%· post 38.68

ClosedNov 6 '26

Mkt cap$4.4BRevenue$156MQ2 FY26Revenue$1.7BFY25

Compare

ClosedNov 6 '26

PFEPfizer Inc

SKTTanger Inc.

29.39▼−0.21%post 29.35

Price

38.68▲+0.74%post 38.68

$167.5B

Mkt cap

$4.4B

Q3 FY26$16.6B

Revenue

$156MQ2 FY26

FY25$62.6B

Revenue

$1.7BFY25

PFE29.39▼−0.21%vsSKT38.68▲+0.74%ClosedNov 6 '26